These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 12768205

  • 21. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P.
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [Abstract] [Full Text] [Related]

  • 22. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
    van der Pol W, Vidarsson G, Vilé HA, van de Winkel JG, Rodriguez ME.
    J Infect Dis; 2000 Oct; 182(4):1139-45. PubMed ID: 10979910
    [Abstract] [Full Text] [Related]

  • 23. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
    Sondermann P, Kaiser J, Jacob U.
    J Mol Biol; 2001 Jun 08; 309(3):737-49. PubMed ID: 11397093
    [Abstract] [Full Text] [Related]

  • 24. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E, Heineke MH, van Egmond M.
    Immunol Rev; 2015 Nov 08; 268(1):123-38. PubMed ID: 26497517
    [Abstract] [Full Text] [Related]

  • 25. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
    Huls G, Heijnen IA, Cuomo E, van der Linden J, Boel E, van de Winkel JG, Logtenberg T.
    Cancer Res; 1999 Nov 15; 59(22):5778-84. PubMed ID: 10582699
    [Abstract] [Full Text] [Related]

  • 26. Immunoglobulin-binding sites of human FcalphaRI (CD89) and bovine Fcgamma2R are located in their membrane-distal extracellular domains.
    Morton HC, van Zandbergen G, van Kooten C, Howard CJ, van de Winkel JG, Brandtzaeg P.
    J Exp Med; 1999 Jun 07; 189(11):1715-22. PubMed ID: 10359575
    [Abstract] [Full Text] [Related]

  • 27. Bivalent binding of IgA1 to FcalphaRI suggests a mechanism for cytokine activation of IgA phagocytosis.
    Herr AB, White CL, Milburn C, Wu C, Bjorkman PJ.
    J Mol Biol; 2003 Mar 28; 327(3):645-57. PubMed ID: 12634059
    [Abstract] [Full Text] [Related]

  • 28. IgA and the IgA Fc receptor.
    van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG.
    Trends Immunol; 2001 Apr 28; 22(4):205-11. PubMed ID: 11274926
    [Abstract] [Full Text] [Related]

  • 29. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A, van Egmond M.
    Front Immunol; 2019 Apr 28; 10():553. PubMed ID: 30984170
    [Abstract] [Full Text] [Related]

  • 30. Size-dependent effect of IgA on the IgA Fc receptor (CD89).
    Reterink TJ, van Zandbergen G, van Egmond M, Klar-Mohamad N, Morton CH, van de Winkel JG, Daha MR.
    Eur J Immunol; 1997 Sep 28; 27(9):2219-24. PubMed ID: 9341762
    [Abstract] [Full Text] [Related]

  • 31. IgA receptors in health and disease.
    Wines BD, Hogarth PM.
    Tissue Antigens; 2006 Aug 28; 68(2):103-14. PubMed ID: 16866880
    [Abstract] [Full Text] [Related]

  • 32. Crystal structure of the complex of rat neonatal Fc receptor with Fc.
    Burmeister WP, Huber AH, Bjorkman PJ.
    Nature; 1994 Nov 24; 372(6504):379-83. PubMed ID: 7969498
    [Abstract] [Full Text] [Related]

  • 33. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89.
    Pleass RJ, Dunlop JI, Anderson CM, Woof JM.
    J Biol Chem; 1999 Aug 13; 274(33):23508-14. PubMed ID: 10438530
    [Abstract] [Full Text] [Related]

  • 34. Characterization of IgA and IgM binding and internalization by surface-expressed human Fcα/μ receptor.
    Yoo EM, Trinh KR, Lim H, Wims LA, Morrison SL.
    Mol Immunol; 2011 Sep 13; 48(15-16):1818-26. PubMed ID: 21632111
    [Abstract] [Full Text] [Related]

  • 35. Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.
    Gomes MM, Wall SB, Takahashi K, Novak J, Renfrow MB, Herr AB.
    Biochemistry; 2008 Oct 28; 47(43):11285-99. PubMed ID: 18826328
    [Abstract] [Full Text] [Related]

  • 36. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.
    Autoimmun Rev; 2013 Apr 28; 12(6):666-9. PubMed ID: 23201915
    [Abstract] [Full Text] [Related]

  • 37. Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression, and function.
    Wines BD, Trist HM, Monteiro RC, Van Kooten C, Hogarth PM.
    J Biol Chem; 2004 Jun 18; 279(25):26339-45. PubMed ID: 15096494
    [Abstract] [Full Text] [Related]

  • 38. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
    Abi-Rached L, Dorighi K, Norman PJ, Yawata M, Parham P.
    J Immunol; 2007 Jun 15; 178(12):7943-54. PubMed ID: 17548632
    [Abstract] [Full Text] [Related]

  • 39. Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells.
    Otten MA, Groenveld I, van de Winkel JG, van Egmond M.
    Immunobiology; 2006 Jun 15; 211(6-8):503-10. PubMed ID: 16920489
    [Abstract] [Full Text] [Related]

  • 40. Monomeric and polymeric IgA show a similar association with the myeloid FcalphaRI/CD89.
    Oortwijn BD, Roos A, van der Boog PJ, Klar-Mohamad N, van Remoortere A, Deelder AM, Daha MR, van Kooten C.
    Mol Immunol; 2007 Feb 15; 44(5):966-73. PubMed ID: 16675016
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.